サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：アスピリンの世界市場：2023-2030年
市場調査レポート
商品コード
1327616

アスピリンの世界市場：2023-2030年

Global Aspirin Market 2023-2030

出版日
ページ情報
英文 156 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
アスピリンの世界市場：2023-2030年
出版日: 2023年07月07日
発行: Orion Market Research
ページ情報: 英文 156 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアスピリン市場は予測期間中（2023-2030年）にCAGR 3.6％で成長すると予測されています。アスピリンのような効果的な鎮痛剤は、疼痛管理を助けることができます。アスピリンには血小板の凝集を防ぐ作用があり、血栓形成の可能性を低下させる。抗血小板作用があるため、動脈における血栓形成のリスクを下げ、心臓発作や脳卒中につながる閉塞を防ぐのに役立ちます。

さらに、アスピリンは、乳がん、前立腺がん、肺がん、卵巣がんなど、特定のがんのリスク低減にも重要な役割を果たしています。例えば、米国国立衛生研究所（NIH）によると、アスピリンは卵巣がんの発症リスクを低下させることが判明しています。しかし、遺伝的変数がこの関連性に影響するかどうかは不明です。影響修飾因子を理解することが重要です。しかし、遺伝的変数が卵巣がんに与える潜在的影響については、まだ完全には明らかになっていないです。卵巣がんの化学予防のためにアスピリンを使用する場合、特定の高リスクサブグループに焦点を当てる必要があると考えられるので、これらの影響修飾因子を理解することは極めて重要です。さらに、アスピリンやクロピドグレルなどの抗血小板薬はアルツハイマー病の治療にも使用されています。これらの薬剤の抗血小板作用は、血栓の形成を防ぐことによって心臓病、脳卒中、アルツハイマー病などの病気を治療するために頻繁に処方されます。例えば、2023年1月、FDAはアルツハイマー病の治療薬としてLEQEMBITM（lecanemab-irmb）を迅速承認しました。アスピリンとクロピドグレルは、両方の治療が必要な患者に対してLEQEMBIと併用可能な抗血栓薬の一例です。

セグメント別の見通し

小売薬局のサブセグメントが世界のアスピリン市場で大きなシェアを占めると予想される

流通チャネルの中では、小売薬局のサブセグメントが世界のアスピリン市場でかなりのシェアを占めると予想されます。アスピリンは、小売店でもオンラインでも購入できる医薬品に頻繁に含まれています。主に鎮痛、解熱、抗炎症作用のために利用されています。小売店での用途としては、店頭販売（OTC）、セルフメディケーション、心臓血管の健康などがあります。アスピリンは自宅からオンラインで簡単に購入できるため、入手しやすく、便利で、大量購入が可能です。ヘルスケアの専門家は、心臓発作や脳卒中などの心血管イベントのリスクが高い人にアスピリンの使用を勧めることが多いです。これらの病気は世界的にますます一般的になっているため、アスピリンは治療・予防薬として人気が高まっています。したがって、心臓疾患の有病率の上昇は、市場拡大の重要な要因です。例えば、2023年7月、Techfields Pharmaは現在、2型糖尿病、心筋梗塞、肺塞栓症、慢性心不全の治療に使用されるアスピリン・トロラミン塩酸塩の臨床研究を実施しています。アスピリン・トロラミン塩酸塩は、粉末の溶液として局所投与することも、スプレーとして経皮投与することもできます。現在進行中のこの研究は、小売市場におけるアスピリンベースの治療薬の成長と開発にさらに貢献しています。

地域別展望

世界のアスピリン市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域によってさらに区分されます。中でもアジア太平洋地域は、Nanjing Pharma techs Co, ltd.、JQC（Huayin）Pharmaceutical Co., Ltd.、Globela Pharma Pvt Ltd.、Trumacヘルスケア、Alta Laboratories Ltd.、Zhenjiang Gaopeng Pharmaceutical CO, Ltd.などの市場ソリューションベンダーが集中していることから、世界全体で大きなシェアを占めると予想されています。

北米はアスピリンの世界市場において著しいCAGRで成長する見込み

北米は、主にCVDの高い有病率と疼痛管理のためのアスピリン需要の増加により、予測期間中に著しいCAGRで成長すると予想されます。NIHによると、アスピリンの使用はCOVID-19患者の死亡リスクの減少と有意に関連しています。一次予防におけるアスピリンの役割は、現在の勧告でも論じられています。さらに，アスピリン治療は心血管イベントの二次予防の手法としてもよく知られています。例えば、2023年7月、Dr. Reddy's Laboratories Ltd.は、ROZAT GOLDという商品名で、人気のあるスタチンと二重抗血小板製剤を発売しました。ロザット・ゴールドは、循環器専門医、顧問医、糖尿病専門医により、慢性で安定した冠動脈疾患などの高リスクの心血管疾患を有する患者への使用が推奨されています。北米では、疼痛管理やCOVID-19関連治療など、さまざまな医療場面でのアスピリンの潜在的な有用性を認識しながら、心血管疾患の管理・予防に注力しているため、こうした要因が重なり、アスピリン市場の成長を牽引しています。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Bayer AG
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Cardinal Health
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • LNK International, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • アスピリンの世界市場：投与経路別
    • 経口
    • 直腸
    • 非経口
  • アスピリンの世界市場：剤形別
    • 錠剤
    • 静脈注射
    • カプセル
    • シロップ剤
    • その他（徐放剤、遅延放出剤、チュアブル剤）
  • アスピリンの世界市場：用途別
    • 疼痛
    • 深部静脈血栓症
    • 発熱および炎症
    • その他
  • アスピリンの世界市場：製品タイプ別
    • 単独製品
    • 配合製品
  • アスピリンの世界市場：流通チャネル別
    • ホスピタリティ薬局
    • 小売薬局
    • オンライン薬局

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Advance Pharmaceutical Inc.
  • Alta laboratories Ltd.
  • Endo International plc
  • Globalimpoter Inc.
  • Globela Pharma Pvt Ltd.
  • J.M Loveridge Ltd.
  • JQC（Huayin）Pharmaceutical co., Ltd.
  • Nanjing Pharmatechs Co., Ltd.
  • Perrigo Company plc
  • Seqens
  • St. Joseph Aspirin
  • Thermo fisher scientific
  • Trumac Healthcare
  • Umang Pharmatechs co,.Ltd.
  • Zhenjiang Gaopeng Pharmaceutical co,.Ltd.
図表

LIST OF TABLES

  • 1. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)2022-2030 ($ MILLION)
  • 2. GLOBAL ORAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL RECTAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 4. GLOBAL PARENTENAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 5. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
  • 6. GLOBAL ASPIRIN IN TABLETS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL ASPIRIN IN INTRAVENOUS INJECTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL ASPIRIN IN CAPSULES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL ASPIRIN IN OTHER FORMS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 11. GLOBAL ASPIRIN FOR PAIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 12. GLOBAL ASPIRIN FOR DEEP VEIN THROMBOSIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 13. GLOBAL ASPIRIN FOR FEVER AND INFLAMMATION MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 14. GLOBAL ASPIRIN FOR OTHER TREATMENTS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 15. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 16. GLOBAL ASPIRIN IN ALONE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. GLOBAL ASPIRIN IN COMBINATION PRODUCT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 19. GLOBAL ASPIRIN IN HOSPITALS PHARMACIES MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
  • 20. GLOBAL ASPIRIN IN RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
  • 21. GLOBAL ASPIRIN IN ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
  • 22. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
  • 25. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
  • 26. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 27. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 28. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 29. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 30. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
  • 31. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
  • 32. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 33. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 34. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 35. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 36. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
  • 37. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
  • 38. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 39. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 40. ASIA- PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 41. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
  • 42. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
  • 43. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 44. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 45. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ASPIRIN MARKET SHARE BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
  • 2. GLOBAL ORAL ASPIRIN MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL RECTAL ASPIRIN MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PARENTENAL ASPIRIN MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022 VS 2030 (%)
  • 6. GLOBAL ASPIRIN IN TABLETS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL ASPIRIN IN INTRAVENOUS INJECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL ASPIRIN IN CAPSULES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL ASPIRIN IN OTHERS FORMS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022 VS 2030 (%)
  • 11. GLOBAL ASPIRIN FOR PAIN MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL ASPIRIN FOR DEEP VEIN THROMBOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL ASPIRIN FOR FEVER AND INFLAMMATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL ASPIRIN FOR OTHER TREATMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022 VS 2030 (%)
  • 16. GLOBAL ASPIRIN IN ALONE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL ASPIRIN IN COMBINATION PRODUCT MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 18. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • 19. GLOBAL ASPIRIN IN HOSPITALS PHARMACIES MARKET RESEARCH AND ANALYSIS 2022 VS 2030 (%)
  • 20. GLOBAL ASPIRIN IN RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS 2022 VS 2030 (%)
  • 21. GLOBAL ASPIRIN IN ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS 2022 VS 2030 (%)
  • 22. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 23. US ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CANADA ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. UK ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. FRANCE ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. GERMANY ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. ITALY ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. SPAIN ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF EUROPE ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. INDIA ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. CHINA ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
  • 33. JAPAN ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
  • 34. SOUTH KOREA ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
  • 35. REST OF ASIA-PACIFIC ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
  • 36. REST OF THE WORLD ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027526

Title: Global Aspirin Market Size, Share & Trends Analysis Report by Route of Administration (Oral, Rectal, and Parenteral), by Dosage Form (Tablets, Intravenous Injections, Capsules, and Others), by Applications (Pain, Deep vein Thrombosis, Fever and Inflammation and Others), by Product Type (Alone, Combination Products), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies),Forecast Period (2023-2030).

The global aspirin market is anticipated to grow at a CAGR of 3.6% during the forecast period (2023-2030). Effective analgesics, such as aspirin, can aid in pain management. Aspirin has the ability to prevent platelet aggregation, reducing the likelihood of blood clot formation. Due to its antiplatelet effect, helping to lower the risk of blood clot formation in the arteries and preventing blockages that can lead to heart attack or stroke.

Moreover, Aspirin plays a significant role in reducing the risk of certain cancers, including breast cancer, prostate cancer, lung cancer, and ovarian cancer. For instance, according to the National Institute of Health (NIH), aspirin has been found to lower the risk of developing ovarian cancer. however, it is unclear whether hereditary variables affect this link. Understanding impact modifiers is However, the potential impact of hereditary variables on this is still not entirely clear. Understanding these impact modifiers is crucial, as any aspirin usage for ovarian cancer chemoprevention would likely need to focus on specific higher-risk subgroups. Additionally, antiplatelet drugs, including aspirin and clopidogrel, are also used in the treatment of Alzheimer's disease. These antiplatelet effects of these drugs are frequently prescribed to treat illnesses such as heart disease, stroke, and Alzheimer's disease by preventing the formation of clots. For Instance, in January 2023, FDA granted expedited approval to LEQEMBITM (lecanemab-irmb) for the treatment of Alzheimer's disease. Aspirin and clopidogrel are examples of antithrombotic drugs that can be used in combination with LEQEMBI for individuals who require both treatments.

Segmental Outlook

The global aspirin market is segmented by route of administration, dosage form, application, product and distribution channel. Based on the route of administration the market is sub-segmented into oral, rectal, and parenteral. Based on the dosage form, the market is sub-segmented into tablets, intravenous injections, capsules, and others (syrup). Based on the application, the market is sub-segmented into pain, deep vein thrombosis, fever and inflammation and others. Based on the product type, the market is bifurcated into alone and combination. Furthermore, on the basis of the distribution channel the market is sub-segmented into hospitals pharmacies, retail pharmacies, and online pharmacies. Among the dosage forms tablets and capsules sub-segment is anticipated to hold a considerable share of the market owing to the rise in the development of market growth.

The Retail Pharmacies Sub-Segment is Anticipated to Hold a Considerable Share of the Global Aspirin Market

Among the distribution channel, the retail sub-segment is expected to hold a considerable share of the global aspirin market. Aspirin is frequently found in pharmaceuticals that can be purchased both at retail stores and online. It is primarily utilized for its analgesic, antipyretic, and anti-inflammatory effects. Its retail applications include over-the-counter (OTC) sales, self-medication, and cardiovascular health. Aspirin can be easily purchased online from the comfort of one's home, offering accessibility, convenience, and ability for large-scale purchasing. Healthcare professionals often advise aspirin use for people who are at high risk for cardiovascular events, such as heart attacks and strokes, two prevalent conditions that aspirin is regularly used to treat and prevent. As these illnesses are becoming increasingly common globally, aspirin is gaining popularity as a therapeutic and preventive tool. Therefore, the rise in the prevalence of heart disorders is a key factor in the market's expansion. For Instance, in July 2023, Techfields Pharma is currently conducting clinical research on aspirin trolamine hydrochloride, which is used in the treatment of type 2 diabetes, myocardial infarction, pulmonary embolism, and chronic heart failure. Aspirin trolamine hydrochloride can be administered both topically as a powder for a solution and transdermal as a spray. This ongoing research further contributes to the growth and development of aspirin-based treatments in the retail segment of the market.

Regional Outlook

The global aspirin market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, the Asia-Pacific region is anticipated to hold a prominent share of the market across the globe, owing to the high concentration of the market solution vendors including Nanjing Pharma techs Co, ltd., JQC (Huayin) Pharmaceutical Co., Ltd., Globela Pharma Pvt Ltd, Trumac Healthcare, Alta Laboratories Ltd, Zhenjiang Gaopeng Pharmaceutical CO, Ltd., and others.

North America is Expected to Grow at a Significant CAGR in the Global Aspirin Market

North America is expected to grow at a significant CAGR over the forecast period, primarily due to the high prevalence of CVDs and the increasing demand for aspirin for pain management. According to the NIH, aspirin use has been significantly associated with a decreased risk of mortality among COVID-19 individuals. Aspirin's role in primary prevention is also discussed in current recommendations. Moreover, aspirin treatment is well-acknowledged as a technique for the secondary prevention of cardiovascular events. For instance, in July 2023, Dr. Reddy's Laboratories Ltd. launched a popular statin and dual antiplatelet formulation under the trade name ROZAT GOLD. Rozat Gold is recommended for use in patients with high-risk cardiovascular conditions, such as chronic and stable coronary illnesses, by cardiologists, consulting physicians, and diabetologists. The combination of these factors is driving the growth of the aspirin market in North America, as the region focuses on managing and preventing cardiovascular diseases while recognizing the potential benefits of aspirin in various medical contexts, including its use in pain management and COVID-19 related care.

Market Players Outlook

The major companies serving the aspirin market include: Allegiant Health, Par Pharmaceutical, St. Joseph's Aspirin, Thermo Fisher Scientific Inc., Chemische Fabrik Weyl GmbH, Eli Lilly, Lohmann LTS, and Upjohn Co. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2022, Bayer AG brand Alka-Seltzer®, known for its effervescent antacids and painkillers, collaborated with the producer and musician T-Pain to introduce its newest product, NEW Alka-Seltzer hangover relief. The drug contains high-strength aspirin and caffeine, thus, advised to consumer only two drops in a glass of water for quick relief.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global aspirin market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Bayer AG
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Cardinal Health
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. LNK International, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Aspirin Market by Route of Administration
    • 4.1.1. Oral
    • 4.1.2. Rectal
    • 4.1.3. Parenteral
  • 4.2. Global Aspirin Market by Dosage Form
    • 4.2.1. Tablets
    • 4.2.2. Intravenous Injections
    • 4.2.3. Capsules
    • 4.2.4. Syrups
    • 4.2.5. Others (Extended Release, Delayed Release, Chewable)
  • 4.3. Global Aspirin Market by Applications
    • 4.3.1. Pain
    • 4.3.2. Deep vein Thrombosis
    • 4.3.3. Fever and Inflammation
    • 4.3.4. Others
  • 4.4. Global Aspirin Market by Product Type
    • 4.4.1. Alone
    • 4.4.2. Combination Products
  • 4.5. Global Aspirin Market by Distribution Channel
    • 4.5.1. Hospitals Pharmacies
    • 4.5.2. Retail Pharmacies
    • 4.5.3. Online pharmacies

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Advance Pharmaceutical Inc.
  • 6.2. Alta laboratories Ltd.
  • 6.3. Endo International plc
  • 6.4. Globalimpoter Inc.
  • 6.5. Globela Pharma Pvt Ltd.
  • 6.6. J.M Loveridge Ltd.
  • 6.7. JQC (Huayin) Pharmaceutical co., Ltd.
  • 6.8. Nanjing Pharmatechs Co., Ltd.
  • 6.9. Perrigo Company plc
  • 6.10. Seqens
  • 6.11. St. Joseph Aspirin
  • 6.12. Thermo fisher scientific
  • 6.13. Trumac Healthcare
  • 6.14. Umang Pharmatechs co,.Ltd.
  • 6.15. Zhenjiang Gaopeng Pharmaceutical co,.Ltd.